EMA/ICH – Public consultation: ICH E22 Guideline on general considerations for patient preference studies
Patient preference studies (PPS) aim to assess the relative desirability or acceptability of actual or potential health interventions, or their characteristics and outcomes. PPS can generate structured insights about the relative importance of characteristics, also referred to as attributes, that are considered by patients when making decisions about drugs. These attributes may include, for example, efficacy or safety outcomes or any other potentially relevant characteristics.
This harmonised guideline outlines general considerations about the use, design, conduct, analysis, and submission of PPS aimed at informing drug development, regulatory submission and evaluation, drug approvals and maintenance of such approvals.
The ICH E22 Guideline on general considerations for patient preference studies is open to consultation until 12 April 2026.
Templates and other open consultations can be found on the EMA Website.
OpenEdition vous propose de citer ce billet de la manière suivante :
vroby (18 février 2026). EMA/ICH – Public consultation: ICH E22 Guideline on general considerations for patient preference studies. ELSIBI. Consulté le 12 octobre 2026 à l’adresse https://doi.org/10.58079/15pvz
